Researchers have found that if you have this one specific type of disease and COVID-19, the case fatality rate is at 29%.
According to research published in Blood Cancer Discovery on July 30th, researchers Malin Hultcrantz, M.D., Ph.D., from Memorial Sloan Kettering Cancer Center in New York City and colleagues reported outcomes of COVID-19 patients that have myeloma, or multiple myeloma, which is a type of blood cancer that develops from plasma cells in the bone marrow. The researchers looked at data from 100 multiple myeloma patients that were confirmed to have a COVID-19 infection.
What the researchers found was that of the 75 patients that were admitted, 13 (17%) were placed on mechanical ventilation, and 22 (29%) patients died. The report indicates that of the 25 non-admitted patients, four were asymptomatic and that there was a higher risk of extreme outcomes (Intensive care treatment, required ventilation, death) in Hispanic/Latinos and African American Blacks when compared to White patients. If you are interested in reading more about this study, check out this link here.
Important Coronavirus Information:
- > NEXT STORY: European Nintendo Switch sales spike by 106% during COVID-19 lockdown
- < PREVIOUS STORY: Call of Duty: Warzone racks up 75 million players in under 5 months